AI assistant
AGENUS INC — Director's Dealing 2025
Mar 5, 2025
34023_dirs_2025-03-05_dac6b8b2-5403-4cfc-a70a-92143a9608fa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AGENUS INC (AGEN)
CIK: 0001098972
Period of Report: 2025-02-21
Reporting Person: Buell Jennifer (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-02-21 | Common Stock | A | 626 | $3.32 | Acquired | 15318 | Direct |
Footnotes
F1: At her request and with the approval of the Agenus Inc. Compensation Committee, a portion of Jennifer Buell's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Buell's salary for the pay period ending February 21, 2025. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.
F2: $3.32 is the closing price of our Common Stock on February 21, 2025, the payroll date for the pay period ending February 21, 2025.